{{Rsnum
|rsid=1978503
|Chromosome=18
|position=55997051
|Orientation=plus
|GMAF=0.169
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 62.8 | 30.1 | 7.1
| HCB | 76.5 | 21.3 | 2.2
| JPT | 77.9 | 19.5 | 2.7
| YRI | 66.2 | 31.0 | 2.8
| ASW | 66.7 | 31.6 | 1.8
| CHB | 76.5 | 21.3 | 2.2
| CHD | 68.8 | 26.6 | 4.6
| GIH | 90.1 | 8.9 | 1.0
| LWK | 76.1 | 22.9 | 0.9
| MEX | 74.1 | 24.1 | 1.7
| MKK | 76.8 | 21.9 | 1.3
| TSI | 60.8 | 36.3 | 2.9
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs1978503
|PubMedID=17903305
|Condition=Breast cancer
|Gene=Intergenic
|Risk Allele=
|pValue=1.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1978503
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903305; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Breast cancer.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356380
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1978503
|overall_frequency_n=16
|overall_frequency_d=128
|overall_frequency=0.125
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=13
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}